Cargando…

An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio

Barth syndrome is an X‐linked disorder characterized by cardiomyopathy, skeletal myopathy, and neutropenia, caused by deleterious variants in TAFAZZIN. This gene encodes a phospholipid‐lysophospholipid transacylase that is required for the remodeling of the mitochondrial phospholipid cardiolipin (CL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaz, Frédéric M., van Lenthe, Henk, Vervaart, Martin A. T., Stet, Femke S., Klinkspoor, Johanne H., Vernon, Hilary J., Goorden, Susan M. I., Houtkooper, Riekelt H., Kulik, Willem, Wanders, Ronald J. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291596/ https://www.ncbi.nlm.nih.gov/pubmed/34382226 http://dx.doi.org/10.1002/jimd.12425

Ejemplares similares

Expression of monolysocardiolipin acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart
por: Taylor, William A, et al.
Publicado: (2002)

Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii
por: Lopalco, Patrizia, et al.
Publicado: (2017)

Cardiolipin, and not monolysocardiolipin, preferentially binds to the interface of complexes III and IV
por: Corey, Robin A., et al.
Publicado: (2022)

Cardiolipin provides an essential activating platform for caspase-8 on mitochondria
por: Gonzalvez, Francois, et al.
Publicado: (2008)

Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function
por: Sandlers, Yana, et al.
Publicado: (2016)

Stimulating the sir2–spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome
por: Damschroder, Deena, et al.
Publicado: (2022)

Loss of protein association causes cardiolipin degradation in Barth syndrome
por: Xu, Yang, et al.
Publicado: (2016)

Evaluation of cardiolipin nanodisks as lipid replacement therapy for Barth syndrome
por: Ikon, Nikita, et al.
Publicado: (2018)

COmplexome Profiling ALignment (COPAL) reveals remodeling of mitochondrial protein complexes in Barth syndrome
por: Van Strien, Joeri, et al.
Publicado: (2019)

Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype
por: Bowron, Ann, et al.
Publicado: (2014)

Barth syndrome: A life-threatening disorder caused by abnormal cardiolipin remodeling
por: Raja, Vaishnavi, et al.
Publicado: (2017)

Current Knowledge on the Role of Cardiolipin Remodeling in the Context of Lipid Oxidation and Barth Syndrome
por: Liang, Zhuqing, et al.
Publicado: (2022)

Quality of life in Barth syndrome
por: Kim, Alexander Y., et al.
Publicado: (2022)

Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins
por: Duncan, Anna L.
Publicado: (2020)

Erratum to: Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype
por: Bowron, Ann, et al.
Publicado: (2015)

PLAAT1 Exhibits Phosphatidylcholine:Monolysocardiolipin Transacylase Activity
por: Bradley, Ryan M., et al.
Publicado: (2022)

A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism
por: Reid Thompson, W., et al.
Publicado: (2020)

Treatment of Barth Syndrome by Cardiolipin Manipulation (CARDIOMAN) With Bezafibrate: Protocol for a Randomized Placebo-Controlled Pilot Trial Conducted in the Nationally Commissioned Barth Syndrome Service
por: Dabner, Lucy, et al.
Publicado: (2021)

Correction for The Cardiolipin Transacylase, Tafazzin, Associates with Two Distinct Respiratory Components Providing Insight into Barth Syndrome
Publicado: (2012)

Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome
por: Petit, Patrice X., et al.
Publicado: (2020)

Mitochondrial Fatty Acid Oxidation Disorders: Laboratory Diagnosis, Pathogenesis, and the Complicated Route to Treatment
por: Wanders, Ronald J.A., et al.
Publicado: (2020)

Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth
por: Steward, C G, et al.
Publicado: (2010)

Barthes
por: Culler, Jonathan D.
Publicado: (1987)

Blocking phosphatidylglycerol degradation in yeast defective in cardiolipin remodeling results in a new model of the Barth syndrome cellular phenotype
por: Káňovičová, Paulína, et al.
Publicado: (2021)

Cardiolipin, Mitochondria, and Neurological Disease
por: Falabella, Micol, et al.
Publicado: (2021)

Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H(2)O(2) production in heart and skeletal muscle mitochondria
por: Goncalves, Renata L. S., et al.
Publicado: (2020)

Functional exercise capacity, strength, balance and motion reaction time in Barth syndrome
por: Hornby, Brittany, et al.
Publicado: (2019)

Introducing Barthes /
por: Thody, Philip Malcolm Waller, 1928-
Publicado: (1999)

Barth syndrome
por: JEFFERIES, JOHN L
Publicado: (2013)

Barth syndrome
por: Clarke, Sarah LN, et al.
Publicado: (2013)

A sensitive mass spectrometry platform identifies metabolic changes of life history traits in C. elegans
por: Gao, Arwen W., et al.
Publicado: (2017)

Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome
por: Hornby, Brittany, et al.
Publicado: (2022)

Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data
por: Van den Eynde, Jef, et al.
Publicado: (2023)

Cardiac‐specific succinate dehydrogenase deficiency in Barth syndrome
por: Dudek, Jan, et al.
Publicado: (2015)

Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies
por: Wang, Gang, et al.
Publicado: (2014)

Identification of enzymes involved in oxidation of phenylbutyrate
por: Palir, Neža, et al.
Publicado: (2017)

Barthes para principiantes /
por: Thody, Philip Malcolm Waller, 1928-
Publicado: (1997)

New clinical and molecular insights on Barth syndrome
por: Ferri, Lorenzo, et al.
Publicado: (2013)

Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders
por: Jaspers, Yorrick R. J., et al.
Publicado: (2020)

Arginine kinetics are altered in a pilot sample of adolescents and young adults with Barth syndrome
por: Cade, W. Todd, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7aj194gq51lo68gc802rv4kodv